Rissanen A - Search Results

1

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.

Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators. Astrup A, et al. Among authors: rissanen a. Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Int J Obes (Lond). 2012. PMID: 21844879 Free PMC article. Clinical Trial.

2

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME; NN8022-1807 Study Group. Astrup A, et al. Among authors: rissanen a. Lancet. 2009 Nov 7;374(9701):1606-16. doi: 10.1016/S0140-6736(09)61375-1. Epub 2009 Oct 23. Lancet. 2009. PMID: 19853906 Clinical Trial.

3

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.

Lean ME, Carraro R, Finer N, Hartvig H, Lindegaard ML, Rössner S, Van Gaal L, Astrup A; NN8022-1807 Investigators. Lean ME, et al. Int J Obes (Lond). 2014 May;38(5):689-97. doi: 10.1038/ijo.2013.149. Epub 2013 Aug 14. Int J Obes (Lond). 2014. PMID: 23942319 Free PMC article. Clinical Trial.

4

Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.

Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A. Richelsen B, et al. Among authors: rissanen a. Diabetes Care. 2007 Jan;30(1):27-32. doi: 10.2337/dc06-0210. Diabetes Care. 2007. PMID: 17192328 Clinical Trial.

5

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.

6

Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.

Svendsen M, Rissanen A, Richelsen B, Rössner S, Hansson F, Tonstad S. Svendsen M, et al. Among authors: rissanen a. Obesity (Silver Spring). 2008 Feb;16(2):327-33. doi: 10.1038/oby.2007.82. Obesity (Silver Spring). 2008. PMID: 18239640 Free article. Clinical Trial.

7

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rössner S; RIO-Europe Study Group. Van Gaal LF, et al. Lancet. 2005 Apr 16-22;365(9468):1389-97. doi: 10.1016/S0140-6736(05)66374-X. Lancet. 2005. PMID: 15836887 Free article. Clinical Trial.

8

Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.

Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B. Madsen EL, et al. Among authors: rissanen a. Eur J Endocrinol. 2008 Feb;158(2):179-87. doi: 10.1530/EJE-07-0721. Eur J Endocrinol. 2008. PMID: 18230824 Clinical Trial.

9

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O; RIO-Europe Study Group. Van Gaal LF, et al. Eur Heart J. 2008 Jul;29(14):1761-71. doi: 10.1093/eurheartj/ehn076. Epub 2008 Apr 15. Eur Heart J. 2008. PMID: 18417461 Free article. Clinical Trial.

10

Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).

Kopelman P, Groot Gde H, Rissanen A, Rossner S, Toubro S, Palmer R, Hallam R, Bryson A, Hickling RI. Kopelman P, et al. Among authors: rissanen a. Obesity (Silver Spring). 2010 Jan;18(1):108-15. doi: 10.1038/oby.2009.155. Epub 2009 May 21. Obesity (Silver Spring). 2010. PMID: 19461584 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page